Home            Past Issues            About IP            About IAP           Author Information            Subscription            Advertisement              Search  

   
research paper

Indian Pediatr 2015;52: 769-772

Pulse Oximetry Screening to Detect Cyanotic Congenital Heart Disease in Sick Neonates in a Neonatal Intensive Care Unit

 

NB Mathur, A Gupta and *S Kurien

From the Department of Neonatology, Maulana Azad Medical College; and *Department of Cardiology, GB Pant Hospital;
New Delhi, India.

Correspondence to: Dr NB Mathur, Director-Professor and Head, Department of Neonatology, Maulana Azad Medical College,  New Delhi, India.
Email: [email protected]

Received: November 29, 2014;
Initial review: January 01, 2015;
Accepted: July 01, 2015.



Objective:
To evaluate pulse oximetry for detection of congenital cyanotic heart disease in sick neonates using echocardiography as gold standard.

Methods: Pulse oximetry readings were taken at admission from 950 neonates from right upper limb and either foot with infant breathing room air. Pulse oximetry was considered abnormal if oxygen saturation at room air measured <90% or difference between right hand and foot was more than 3%. Persistent abnormality was considered positive result. Echocardiography was performed on all neonates with positive pulse oximetry (study group) and on one subsequent neonate with negative screen for each neonate with positive screen (controls).

Results: Pulse oximetry was positive in 210 neonates. It detected 20 out of 21 (95.2%) true positives. The sensitivity, specificity, positive predictive value, negative predictive value and odds ratio (95% CI) of pulse oximetry was 95.2%, 52.4 %, 9.5, 99.5 and 22 (5.3, 91.4), respectively.

Conclusion: Pulse oximetry screening is useful in detecting cyanotic heart diseases in sick newborns.

Keywords: Cyanosis, Duct-dependent lesions, Oxygen saturation, Screening.


C
ongenital heart diseases (CHDs) account for 6 -10 % of all the infant deaths, and 20 - 40 % of all infant deaths from malformations [1]. About 25% of CHDs are life threatening and manifest before the first routine clinical examination [1,2]. Challenges in managing CHD in developing countries include delay in diagnosis, transport of sick neonate to tertiary centre, and limited availability of state of the art pediatric cardiac centres [3,4].

The existing pulse oximetry monitoring protocol to detect critical congenital heart disease, is restricted to neonates 24 to 48 hours of age in well infant nursery [5]. A simple algorithm for units catering to sick newborns is challenging because of heterogeneity of underlying conditions; need of studies across a broad range of newborn delivery systems has been expressed [5]. Pulse oximetry as a screening test for congenital cyanotic heart disease has been evaluated among well neonates [2,6-10], but not in sick neonates.The present study was designed to evaluate the utility of pulse oximetry screening in detecting congenital cyanotic heart disease among sick neonates in a referral neonatal unit catering to outborn neonates.

Methods

The study was conducted in the Referral Neonatal Unit of a teaching hospital between April 2013 and January 2014. The unit caters exclusively to outborn sick neonates referred from community hospitals of Delhi and surrounding states, or to those born at home and transported to the hospital directly by the parents. All neonates admitted to the unit during the study period were eligible for inclusion. Neonates in whom stable pulse oximeter signals could not be obtained were excluded. Informed written consent was obtained from the parents of all enrolled subjects. The study was approved by the Institutional ethical committee.

All neonates at admission were clinically evaluated by a resident doctor for temperature, heart rate, respiratory rate (RR), chest retractions, central cyanosis, femoral pulses, other peripheral pulses, capillary filling time, peripheries (cool or warm) and clubbing. Presence of either tachypnea (RR >60/min), retractions, central cyanosis, poor femoral pulses, precordial pulsations, hepatomegaly or murmur was considered as positive clinical examination suggestive of congenital heart diease [11]. Pulse oximetry readings (BPL Excello oximeter with reusable Nellcor Oximax probe accuracy of + 2 %) were taken at admission from right upper limb and either foot with infant breathing room air. The recordings were noted two minutes after stable signals were obtained. Pulse oximetry was considered abnormal if oxygen saturation at room air or on oxygen therapy measured <90% or there was more than 3% difference between right hand and foot [5]. All neonates with abnormal pulse oximetry were subjected to three observations each, separated by at least 1 hour. Screen was considered positive only if the abnormality persisted till the last reading. Echocardio-graphy (Philips iE33 xMATRIX echocardiography system) was performed by a pediatric cardiologist on all neonates with a positive pulse oximetry screen (study group) and on one subsequently enrolled neonate with negative screen per neonate with positive screen (controls).

Data were analyzed using Statistical Package for Social Sciences software (version 21). Student-t test was used for continuous variables and Chi-square test was used for comparing proportions. Multivariate logistical regression (using the forward logistical regression model) was done to find predictors of cyanotic heart disease. Sensitivity, specificity, positive and negative predictive value, positive likelihood ratio and negative likelihood ratio of pulse oximetry in detecting cyanotic heart disease in sick neonates were calculated.

Results

A total of 950 neonates admitted in referral neonatal unit during the study period were screened. Pulse oximetry was positive in 210 neonates, and in five neonates, stable pulse oximeter signals could not be obtained. Fig. 1 shows flow of the study. Out of the 210 controls, 11 neonates (3 with shock, 3 with transient tachypnea of newborn and 5 with pneumonia) had an initial saturation of <90%, but repeat readings were >90%.

Fig. 1 Flow of participants in the study.

Table I compares the baseline demographic and clinical characteristics of cases and controls. Pulse oximetry was positive in 20 out of 21 (95.2%) neonates with echocardiography proven cyanotic heart disease. This included lesions with increased pulmonary blood flow (d-transposition of great arteries, n=8), lesions with decreased pulmonary blood flow (tetrology of Fallot, n=5; double outlet right ventricle with pulmonary atresia/severe pulmonary stenosis, n=3; single ventricle with pulmonary stenosis, n=1) and lesions with pulmonary venous hypertension (obstructed total anomalous pulmonary venous connection, n=3). Pulse oximetry was negative in 1 neonate with tetralogy of Fallot with mild pulmonary stenosis and large left to right shunt.

TABLE I	Comparison of Characteristics of Cases and Controls
Characteristic Cases  Controls
 (n=210) (n=210) 
Age (h),  median (IQR) 72 (24, 183) 120 (48, 240)
Male,  No. (%) 137 (65.2) 125 (59.4)
Gestational age (wk), mean (SD)   37.7 (2.2) 37.4 (2.5)
#Weight (g), median(IQR)   2500 (2081,2900) 2335 (1800, 2786)
Family h/o smoking, No.(%) 9 (4.3) 12 (5.7)
Clinical signs, No. (%)
Tachycardia  >160/min  33 (15.7) 6 (2.9)
Tachypnea >60/min 143 (68.1) 25 (11.9)
Chest retractions 114 (54.3) 69 (32.9)
Central cyanosis 46 (21.9)
Murmur 47 (22.4) 10 (4.8)
Feeble femoral pulses 32 (15.2) 9 (4.3)
Hepatomegaly 37 (17.6) 14 (6.7)
Disease categories
Cyanotic heart disease 20 ( 9.5) 1 (0.5)
Acyanotic heart disease 26 (12.4) 7 (3.3)
Persistent pulmonary  hypertension 18 (8.6) 0
Respiratory diseases 115 ( 54.8) 24 (11.4)
Shock 31 ( 14.8) 9 (4.3)
Others 0 169* (80.4 )
*Sepsis 89, hypoxic ischemic encephalopathy 30, hyper-bilirubinemia 29, healthy preterms 17, hemorrhagic disease of newborn 4; #Admission weight.

The sensitivity, specificity, positive predictive value, negative predictive value, positive likelihood ratio, negative likelihood ratio and odds ratio (95% CI) of pulse oximetry to detect cyanotic congenital heart disease was 95.2%, 52.4% 9.5%, 99.5%, 2.0, 0.1 and 22 (5.3, 91.4), respectively . The sensitivity of pulse oximetry to detect critical congenital heart disease (cyanotic heart disease, n=21 and critical duct dependent systemic lesion, n=1) and PPHN (n=18) was 97.5 % (39/40) with negative predictive value of 99.5% (209/210).

Table II shows pulse oximetry findings in study population. The pre-post ductal difference was >3% only in cases of cyanotic heart disease, coarctation of aorta and persistent pulmonary hypertension of newborn.

TABLE II  Pulse Oximetry Findings in Study Population
SpO2 <90 % Pre-post ductal difference >3% SpO2 90-<95% SpO2 95%
Cyanotic heart disease (n=21) 20  (95.2%) 5 (23.8%) 1 (4.8%) 0
Acyanotic heart disease (n=33) 26  (78.8%) 1 (3.0%) 4 (12.1%) 3 (9.1%)
Persistent pulmonary hypertension (n=18) 18  (100%) 8 (44.4%) 0 0
Respiratory diseases (n=139) 115 (82.7%) 0 13 (9.4%) 11 (7.9%)
Shock (n=40) 31 (77.5%) 0 8 (20%) 1 (2.5 %)
Others (n=169) 0 0 95 (56.2%) 74 (43.8%)

On univariate analysis significant predictors of cyanotic heart disease among sick neonates was positive pulse oximetry, male gender, history of consanguinity, history of pregnancy induced hypertension in mother, family history of congenital heart disease and smoking, and presence of tachycardia, central cyanosis, murmur or hepatomegaly. The significant predictors of cyanotic heart disease among sick neonates on multivariate analysis are outlined in Table III.

TABLE III  Predictors of Cyanotic Heart Disease in Sick Neonates
Predictor  P value   OR (95% CI)
Positive pulse oximetry screen < 0.001 12.9 (3.4, 49.9)
Male gender 0.023 89.3 (1.9,4194.1)
Consanguinity 0.003 282.3 (6.6,11254.9)
PIH 0.003 62.8 (4.2, 94.1)
Family history of smoking 0.011 45.5 (2.4,858.5)
Central cyanosis <0.001 653.3 (30.5, 13998.8)
Murmur <0.001 962.8 (30.0, 30889.1)
PIH – Pregnancy induced hypertension.

Discussion

In the present study, all congenital heart diseases with different hemodynamics, except one case of tetralogy of Fallot, were detected using pulse oximetry screen. The sensitivity and negative predictive values of pulse oximetry screening to detect cyanotic heart disease and critical congenital heart disease were high. Murmur, central cyanosis, male gender, consanguinity, family history of smoking and history of pregnancy induced hypertension were significant predictors of cyanotic heart disease.

Majority of the studies done in well infant nurseries had used the saturation cut-off of less than 95% for abnormal pulse oximetry [7,9,10]. The working group [5] recommended any saturation below 90% as abnormal for pulse oximetry screening in well infant nursery, and recommended three repeated saturations taken hourly if the saturation is between 90% and 95%. In our study, only one case of cyanotic heart disease (teralogy of Fallot) had a saturation persisting between 90% and 95% . Considering a persistent saturation value of <95% as criteria for positive pulse oximetry screen would have led to 120 additional referrals for echocardiography. Specificity of pulse oximetry was low because it was also positive in cases of respiratory diseases, acyanotic heart diseases with congestive heart failure, shock and persistent pulmonary hypertension which are common in neonatal intensive care settings. Persistent pulmonary hypertension and hypoxic cardiac conditions have been considered as secondary targets of pulse oximetry screening [5,9,12].

The limitations of present study include single center-based enrolment, and no a priori sample size calculation. Also, echocardiography was done only on selected controls rendering calculations of sensitivity, specificity and predictive values inaccurate.

To conclude, pulse oximetry screening is useful in detecting cyanotic heart diseases in a setting catering to sick out born neonates. Negative predictive value of pulse oximetry is high, making it useful to reliably rule out critical congenital heart disease or PPHN among sick neonates, thus avoiding need for an urgent echocardiography.

 


What This Study Adds?

• Pulse oximetry screening is useful in detecting cyanotic heart diseases, critical duct-dependent systemic lesions and persistent pulmonary hypertension in sick neonates.

References

1. Wren C, Reinhardt Z, Khwaja K. Twenty year trends in diagnosis of life threatening neonatal cardiovascular malformations. Arch Dis Child Fetal Neonatal Ed. 2008;93:F33-7.

2. Vaidyanathan B, Satish G, Mohannan ST, Sundaram KR, Warrier KKR, Kumar RK. Clinical screening for congenital heart disease at birth: A prospective study in a community hospital in Kerala. Indian Pediatr. 2011;48:25-30.

3. Bakshi KD, Vaidyanathan B, Sundaram KR, Roth SJ, Shivaprakasha K, Rao SG, et al. Determinants of early outcome after neonatal heart surgery in a developing country. J Thoracic Cardio Vascular Surgery. 2007;134:765-71.

4. Brown KL, Ridout DA, Hoskote A, Verhulst L, Ricci M, Bull C. Delayed diagnosis of congenital heart disease worsens preoperative condition and outcome of surgery in neonates. Heart. 2006;92:1298-302.

5. Kemper AR, Mahle WT, Martin GR, Cooley WC, Kumar P, Morrow WR, et al. Strategies for implementing screening for critical congenital heart disease. Pediatrics. 2011;128:e1259-67.

6. Sendelbach DM, Jackson GL, Lai SS, Fixler DE, Stehel EK, Engle WD. Pulse oximetry screening at 4 hours of age to detect critical congenital heart defects. Pediatrics. 2008;122:e815-20.

7. Ewer AK, Middleton LJ, Furmston AT, Bhoyar A, Daniels JP, Thangaratinam S, et al. Pulseox Study Group. Pulse oximetry screening for congenital heart defects in newborn infants (Pulseox): A test accuracy study. Lancet. 2011;378:785-94.

8. Arlettaz R, Bauschatz AS, Monkoff Messers B, Bauersfeld U. The contribution of pulse oximetry for early diagnosis of congenital heart disease in newborns. Eur J Pediatr. 2006;165:94-8.

9. de-Wahl Granelli A, Wennergren M, Sandberg K, Mellander M, Bejlum C, Inganas N, et al. Impact of pulse oximetry screening on the detection of duct dependent congenital heart disease: A Swedish prospective screening study in 39,821 newborns. BMJ. 2009;338: a3037.

10. Meberg A, Andreasson A, Brunvand L, Markestad T, Moster D, Nietsch L, et al. Pulse oximetry screening as a complimentary strategy to detect critical congenital heart defects. Acta Paediatr. 2009;98:682-6.

11. Koppel LR, Druschel CM, Carter T, Goldberg BE, Mehta PN, Talwar R, et al. Effectiveness of pulse oximetry screening for congenital heart disease in asymptomatic newborns. Pediatrics. 2003;111:451-5.

12. Thangaratinam S, Brown K, Zamora J, Khan KS, Ewer AK. Pulse oximetry screening for critical congenital heart defects in asymptomatic newborn babies: a systematic review and meta-analysis. Lancet. 2012;379:2459-64.

13. Haq FU, Jalil F, Hashmi S, Jumani MI, Imdad A, Jabeen M, et al. Risk factors predisposing to congenital heart defects. Ann Pediatr Cardiol. 2011;4:117-21.   

 

Copyright © 1999-2015 Indian Pediatrics